Doximity Q3 revenue up 25% YoY to $168.6M; adjusted EBITDA up 39%

Doximity, Inc.

2025-Q3 EPS reported $0.80 revenue$432,111,000

GAAP net income $75.2M ($0.37 diluted EPS) vs $48.0M YoY; non-GAAP net income $91.4M ($0.45) vs $58.5M.
Revenue $168.6M (+25% YoY); adjusted EBITDA $102.0M, margin 60.5%.
Record engagement: 610,000+ unique providers using clinical workflow tools; AI tools up 60% QoQ.
Q4 guidance: revenue $132.5–$133.5M; adjusted EBITDA $62.5–$63.5M; FY2025 revenue guidance raised to $564.6–$565.6M.
Operating cash flow $65.2M (+30% YoY); free cash flow $63.4M (+30% YoY).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.